<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://142-54-23-223.fusionmedialtd.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 15 Jul 2026 09:33:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://142-54-23-223.fusionmedialtd.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  4          Neuronetics, Inc.         For: Jul 14  Filed by: Chernett Jorey</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jul+14++Filed+by%3A+Chernett+Jorey/26772118.html</link>
   <description>si-local-file:///var/storage/secattach/20260715/26772118.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jul+14++Filed+by%3A+Chernett+Jorey/26772118.html</guid>
   <pubDate>Wed, 15 Jul 2026 09:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Form  4          Neuronetics, Inc.         For: Jul 14  Filed by: Chernett Jorey</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jul+14++Filed+by%3A+Chernett+Jorey/26772118.html</link>
   <description>si-local-file:///var/storage/secattach/20260715/26772118.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jul+14++Filed+by%3A+Chernett+Jorey/26772118.html</guid>
   <pubDate>Wed, 15 Jul 2026 09:33:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Form  3          Neuronetics, Inc.         For: Jul 01  Filed by: Anderson Cory</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jul+01++Filed+by%3A+Anderson+Cory/26762628.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26762628.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jul+01++Filed+by%3A+Anderson+Cory/26762628.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Form  3          Neuronetics, Inc.         For: Jul 01  Filed by: Anderson Cory</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jul+01++Filed+by%3A+Anderson+Cory/26762628.html</link>
   <description>si-local-file:///var/storage/secattach/20260713/26762628.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jul+01++Filed+by%3A+Anderson+Cory/26762628.html</guid>
   <pubDate>Mon, 13 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics to Participate in a Panel Discussion at B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit on July 16, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</link>
   <description>
&lt;p&gt;MALVERN, Pa., July  06, 2026  (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a leader in interventional mental health that combines its NeuroStar® TMS technology with direct patient care through the Greenbrook network of interventional psychiatry clinics, today announced that management will participate at the B. Riley Securities&amp;apos; Mind, Muscle &amp;amp; Vision Summit, an invitation-only institutional investor event being held in-person at the InterContinental Boston.&lt;br/&gt;&lt;br/&gt;Neuronetics will participate in a panel discussion titled &amp;quot;Commercializing the Next Wave of Novel Neuropsychiatric Drugs,&amp;quot; alongside Compass Pathways, scheduled for Thursday, July 16, 2026. Management will also be available for one-on-one meetings with institutional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Neuronetics+to+Participate+in+a+Panel+Discussion+at+B.+Riley+Securities%26apos%3B+Mind%2C+Muscle+%26amp%3B+Vision+Summit+on+July+16%2C+2026/26733203.html</guid>
   <pubDate>Mon, 06 Jul 2026 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.50202486</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CMPS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20026344</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.47928049</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.53171475</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics promotes CTO to EVP, General Manager of Greenbrook</title>
   <link>http://www.streetinsider.com/Corporate+News/Neuronetics+promotes+CTO+to+EVP%2C+General+Manager+of+Greenbrook/26680144.html</link>
   <description>&lt;p&gt;Neuronetics Inc. (NASDAQ: STIM) has promoted Cory Anderson from Senior Vice President and Chief Technology Officer to Executive Vice President and General Manager of Greenbrook, effective July 1, 2026.&lt;/p&gt;&lt;p&gt;The promotion was approved by the company's board of directors on June 16, 2026, according to a statement from the company.&lt;/p&gt;&lt;p&gt;Anderson, 49, has held several roles at Neuronetics since joining in March 2021, most recently serving as SVP R&amp;D and Clinical, Chief Technology Officer since January 2025. Before joining Neuronetics, he held positions at Sebacia, The Innovation Factory, and Accuitive Medical Ventures, and earlier worked in product development and marketing at Novoste</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Neuronetics+promotes+CTO+to+EVP%2C+General+Manager+of+Greenbrook/26680144.html</guid>
   <pubDate>Tue, 23 Jun 2026 16:42:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Neuronetics promotes CTO to EVP, General Manager of Greenbrook</title>
   <link>http://www.streetinsider.com/Management+Changes/Neuronetics+promotes+CTO+to+EVP%2C+General+Manager+of+Greenbrook/26680144.html</link>
   <description>&lt;p&gt;Neuronetics Inc. (NASDAQ: STIM) has promoted Cory Anderson from Senior Vice President and Chief Technology Officer to Executive Vice President and General Manager of Greenbrook, effective July 1, 2026.&lt;/p&gt;&lt;p&gt;The promotion was approved by the company's board of directors on June 16, 2026, according to a statement from the company.&lt;/p&gt;&lt;p&gt;Anderson, 49, has held several roles at Neuronetics since joining in March 2021, most recently serving as SVP R&amp;D and Clinical, Chief Technology Officer since January 2025. Before joining Neuronetics, he held positions at Sebacia, The Innovation Factory, and Accuitive Medical Ventures, and earlier worked in product development and marketing at Novoste</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Changes/Neuronetics+promotes+CTO+to+EVP%2C+General+Manager+of+Greenbrook/26680144.html</guid>
   <pubDate>Tue, 23 Jun 2026 16:42:03 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Form  8-K        Neuronetics, Inc.         For: Jun 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jun+16/26680086.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26680086.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jun+16/26680086.html</guid>
   <pubDate>Tue, 23 Jun 2026 16:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Form  8-K        Neuronetics, Inc.         For: Jun 16</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jun+16/26680086.html</link>
   <description>si-local-file:///var/storage/secattach/20260623/26680086.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jun+16/26680086.html</guid>
   <pubDate>Tue, 23 Jun 2026 16:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
  <item>
   <title>Form  4          Neuronetics, Inc.         For: Jun 15  Filed by: Amin Avinash</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jun+15++Filed+by%3A+Amin+Avinash/26660757.html</link>
   <description>si-local-file:///var/storage/secattach/20260617/26660757.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Neuronetics%2C+Inc.+++++++++For%3A+Jun+15++Filed+by%3A+Amin+Avinash/26660757.html</guid>
   <pubDate>Wed, 17 Jun 2026 16:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.02295732</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">STIM</category>
   	  </item>
 </channel>
</rss>
